Patents by Inventor Steven Philip Keeling

Steven Philip Keeling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions
    Publication number: 20120277279
    Abstract: The present invention provides compounds of formula (I): a process for their preparation, to pharmaceutical compositions comprising the compounds and the preparation of said compositions, to intermediates and to use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or auto-immune conditions.
    Type: Application
    Filed: July 13, 2012
    Publication date: November 1, 2012
    Inventors: Heather Anne BARNETT, Ian Baxter Campbell, Diane Mary Coe, Anthony William James Cooper, Graham George Adam Inglis, Haydn Terence Jones, Steven Philip Keeling, Simon John Fawcett MacDonald, Iain McFarlane McLay, Philip Alan Skone, Gordon Gad Weingarten, James Michael Woolven
  • Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditions
    Patent number: 8247377
    Abstract: The present invention provides compounds of formula (I): a process for their preparation, to pharmaceutical compositions comprising the compounds and the preparation of said compositions, to intermediates and to use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or autoimmune conditions.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: August 21, 2012
    Assignee: Glaxo Group Limited
    Inventors: Heather Anne Barnett, Ian Baxter Campbell, Diane Mary Coe, Anthony William James Cooper, Graham George Adam Inglis, Haydn Terence Jones, Steven Philip Keeling, Simon John Fawcett MacDonald, Iain McFarlane McLay, Philip Alan Skone, Gordon Gad Weingarten, James Michael Woolven
  • NOVEL COMPOUNDS
    Publication number: 20100234441
    Abstract: The present invention provides compounds of formula (I): a process for their preparation, to pharmaceutical compositions comprising the compounds and the preparation of said compositions, to intermediates and to use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or autoimmune conditions.
    Type: Application
    Filed: June 11, 2007
    Publication date: September 16, 2010
    Inventors: Heather Anne Barnett, Ian Baxter Campbell, Diane Mary Coe, Anthony William James Cooper, Graham George Adam Inglis, Haydn Terence Jones, Steven Philip Keeling, Simon John Fawcett MacDonald, Iain McFarlane McLay, Philip Alan Skone, Gordon Gad Weingarten, James Michael Woolven
  • PYRAZOLE DERIVATIVES AS NON-STEROIDAL GLUCOCORTICOID RECEPTOR LIGANDS
    Publication number: 20100035926
    Abstract: The present invention provides compounds of formula (I): a process for their preparation, to pharmaceutical compositions comprising the compounds and the preparation of said compositions, to intermediates, and to use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation.
    Type: Application
    Filed: December 19, 2007
    Publication date: February 11, 2010
    Inventors: Ian Baxter Campbell, Diane Mary Coe, Anthony William James Cooper, Graham George Adam Inglis, Haydn Terence Jones, Steven Philip Keeling, Simon John Fawcett MacDonald, Philip Alan Skone, Gordon Gad Weingarten
  • 4-Aminoquinoline-3-Carboxamide Derivatives as Pde4 Inhibitors
    Publication number: 20080096884
    Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof are inhibitors of phosphodiesterase type IV (PDE4) and are of use in the treatment of inflammatory and/or allergic diseases.
    Type: Application
    Filed: September 23, 2004
    Publication date: April 24, 2008
    Inventors: Christopher D. Edlin, Colin David Eldred, Steven Philip Keeling, Christopher James Lunniss, Tracy Jane Redfern, Alison Judith Redgrave, Michael Woodrow
  • Compounds useful in the treatment of inflammatory diseases
    Patent number: 6867192
    Abstract: There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: March 15, 2005
    Inventors: Duncan Robert Armour, David Brown, Miles Stuart Congreve, Paul Martin Gore, Darren Victor Steven Green, Stuart Holman, Torquil Iain Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morriss, Nigel Grahame Ramsden, Peter Ward
  • Novel aqueous anti-inflammatory pharmaceutical formulation
    Publication number: 20040044035
    Abstract: The present invention relates to a pharmaceutical formation which comprises an aqueous suspension of particulate (2S)-3-[4-({[4-aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino]propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of allergic rhinitis are also described, as are containers containing said formulation.
    Type: Application
    Filed: August 21, 2003
    Publication date: March 4, 2004
    Inventors: Duncan Robert Armour, David Brown, Miles Stuart Congreve, Paul Martin Gore, Darren Victor, Steven Green, Stuart Holman, Torquil Iain, Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morriss, Nigel Grahame Ramsden, Marian Thomas, Peter Ward
  • Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonist
    Publication number: 20040037784
    Abstract: The present invention relates to a dry powder pharmaceutical formulation suitable for inhalation therapy comprising particulate (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof and one or more suitable excipients. Methods and uses of the formulation in the treatment of inflammatory diseases are also described, as are medicament packs and inhalation devices containing said formulation.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 26, 2004
    Inventors: Duncan Robert Armour, David Brown, Miles Stuart Congreve, Paul Martin Gore, Darren Victor Steven Green, Stuart Holman, Torquil Iain Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morris, Nigel Grahame Ramsden, Marian Thomas, Peter Ward
  • Pharmaceutical anti-inflammatory aerosol formulation
    Publication number: 20040039021
    Abstract: The present invention relates to a pharmaceutical aerosol formulation comprising a hydrofluoroalkane (HFA) propellant having suspended therein particulate (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of respiratory disorders are also described, as are canisters and metered dose inhalers containing said formulation.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 26, 2004
    Inventors: Duncan Robert Armour, David Brown, Miles Congreve, Paul Gore, Darren Victor, Steven Green, Stuart Holman, Torquil Iain, Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morriss, Nigel Grahame Ramsden, Marian Thomas, Peter Ward